Guidelines
Free Access
Japanese guideline for diagnosis and treatment of interstitial cystitis
Yukio Homma,
Tomohiro Ueda, Takaaki Ito,
Mineo Takei, Hikaru Tomoe,
Yukio Homma
Departments of Urology, Tokyo University Graduate School of Medicine, Tokyo,
Search for more papers by this authorTakaaki Ito
Urology, Hachiouji Medical Center, Tokyo Medical University, Hachiouji, Tokyo,
Search for more papers by this authorHikaru Tomoe
Urology, Tokyo Women's Medical University Medical Center East, Tokyo, Japan
Search for more papers by this authorYukio Homma,
Tomohiro Ueda, Takaaki Ito,
Mineo Takei, Hikaru Tomoe,
Yukio Homma
Departments of Urology, Tokyo University Graduate School of Medicine, Tokyo,
Search for more papers by this authorTakaaki Ito
Urology, Hachiouji Medical Center, Tokyo Medical University, Hachiouji, Tokyo,
Search for more papers by this authorHikaru Tomoe
Urology, Tokyo Women's Medical University Medical Center East, Tokyo, Japan
Search for more papers by this authorYukio Homma, md, phd, Department of Urology, Tokyo University Graduate School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan. Email: [email protected].
Abstract
Interstitial cystitis (IC) is a disease of the urinary bladder with lower urinary tract symptoms such as urinary frequency, bladder hypersensitivity and/or bladder pain and resultant serious impairment of quality of life. In Japan, assuming that IC is very rare, research activity and medical care of IC have been sparse until 2001, when the Society of Interstitial Cystitis of Japan (SICJ) and a patient support group were founded.1,2 Subsequently the International Consultation on Interstitial Cystitis Japan (ICICJ) was held in Kyoto in 2003.3 On the other hand, the etiology of IC has not been well clarified, which complicates its diagnosis and treatment at clinical settings. We have thus developed the Japanese Clinical Guideline,4 which is targeted at healthcare professionals including specialists in urology and women's health care who may engage in the diagnosis and treatment of IC. This article is the English translation of a shortened version of the Guideline for convenience of readers worldwide.
References
- 1 Society of Interstitial Cystitis of Japan. Available at URL: http://sicj.umin.jp/http://sicj.umin.jp/
- 2 Homepage of the patient group. Available at URL: http://www.tomonoki.org/
- 3 International Consultation on Interstitial Cystitis Japan (ICICJ). Int. J. Urol. 2003; 10 (Suppl).
- 4 Homma Y, Ueda T, Ito T, Takei M, Tomoe H. Clinical Guidelines For Interstitial Cystitis. Blackwell Publishing, Tokyo, 2007.
- 5 Hanno P, Baranowski A, Fall M et al. Painful bladder syndrome including interstitial cystitis. In: P Abrams, L Cardozo, S Khoury, A Wein (eds). Incontinence. Health Publication, St Helier, 2005; 1455–520.
- 6 Guideline for chronic pelvic pain by European Association of Urology. Available at URL: http://www.uroweb.org/files/uploaded_files/guidelines/chronicpelvicpain.pdf
- 7 Goldman HB. Interstitial cystitis the great enigma. J. Urol. 2000; 164: 1921.
- 8 Hanno PM, Landis JR, Matthews-Cook Y, Kusek J, Nyberg L Jr. The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health Interstitial Cystitis Database study. J. Urol. 1999; 161: 553–7.
- 9 Sant GR, Hanno PM. Interstitial cystitis: current issues and controversies in diagnosis. Urology 2001; 57: 82–8.
- 10 Diokno AC, Homma Y, Sekiguchi Y, Suzuki Y. Interstitial cystitis, gynecologic pelvic pain, prostatitis, and their epidemiology. Int. J. Urol. 2003; 10 (Suppl): S3–6.
- 11 Leiby BE, Landis JR, Propert KJ, Tomaszewski JE. Discovery of morphological subgroups that correlate with severity of symptoms in interstitial cystitis: a proposed biopsy classification system. J. Urol. 2007; 177: 142–8.
- 12 Abrams P, Cardozo L, Fall M et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol. Urodyn. 2002; 21: 167–78.
- 13 Irwin P, Samsudin A. Reinvestigation of patients with a diagnosis of interstitial cystitis: common things are sometimes common. J. Urol. 2005; 174: 584–7.
- 14 Peeker R, Enerback L, Fall M, Aldenborg F. Recruitment, distribution and phenotypes of mast cells in interstitial cystitis. J. Urol. 2000; 163: 1009–15.
- 15 Hofmeister MA, He F, Ratliff TL, Mahohey T, Becich MJ. Mast cells and nerve fibers in interstitial cystitis (IC): an algorithm for histologic diagnosis via quantitative image analysis and morphometry (QIAM). Urology 1997; 49: 41–7.
- 16 Fall M, Johansson SL, Aldenborg F. Chronic interstitial cystitis: a heterogeneous syndrome. J. Urol. 1987; 137: 35–8.
- 17 Dundore PA, Schwartz AM, Semerjian H. Mast cell counts are not useful in the diagnosis of nonulcerative interstitial cystitis. J. Urol. 1996; 155: 885–7.
- 18 Parsons CL, Lilly JD, Stein P. Epithelial dysfunction in nonbacterial cystitisiinterstitial cystitisi. J. Urol. 1991; 145: 732–5.
- 19 Keay S, Kleinberg M, Zhang CO, Hise MK, Warren JW. Bladder epithelial cells from patients with interstitial cystitis produce an inhibitor of heparin-binding epidermal growth factor-like growth factor production. J. Urol. 2000; 164: 2112–18.
- 20 Keay S, Seillier-Moiseiwitsch F, Zhang CO, Chai TC, Zhang J. Changes in human bladder epithelial cell gene expression associated with interstitial cystitis or antiproliferative factor treatment. Physiol. Genomics 2003; 14: 107–15.
- 21 Oravisto KJ. Interstitial cystitis as an autoimmune disease. A review. Eur. Urol. 1980; 6: 10–13.
- 22 Anderson JB, Parivar F, Lee G et al. The enigma of interstitial cystitis: an autoimmune disease? Br. J. Urol. 1989; 63: 58–63.
- 23 Tan EM. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv. Immunol. 1989; 44: 93–151.
- 24 Ochs RL. Autoantibodies and interstitial cystitis. Clin. Lab. Med. 1997; 17: 571–9.
- 25 Leppilahti M, Tammela TL, Huhtala H, Kiilholma P, Leppilahti K, Auvinen A. Interstitial cystitis-like urinary symptoms among patients with Sjogren's syndrome: a population-based study in Finland. Am. J. Med. 2003; 115: 62–5.
- 26 Domingue GJ, Ghoniem GM, Bost KL, Fermin C, Human LG. Dormant microbes in interstitial cystitis. J. Urol. 1995; 153: 1321–6.
- 27 Lynes WL, Sellers RG, Shortliffe LMD. The evidence for occult bacterial infections as a cause for interstitial cystitis. J. Urol. 1989; 141: 268A.
- 28 Duncan JL, Schaeffer AJ. Do infectious agents cause interstitial cystitis? Urology 1997; 49: 48–51.
- 29 Christmas TJ, Rode J, Chapple CR, Milroy EJ, Turner-Warwick RT. Nerve fibre proliferation in interstitial cystitis. Virchows Arch. A Pathol Anat. Histopathol. 1990; 416: 447–51.
- 30 Hohenfellner M, Nunes L, Schmidt RA, Lampel A, Thuroff JW, Tanagho EA. Interstitial cystitis: increased sympathetic innervation and related neuropeptide synthesis. J. Urol. 1992; 147: 587–91
- 31 Palea S, Artibani W, Ostardo E, Trist DG, Pietra C. Evidence for purinergic neurotransmission in human urinary bladder affected by interstitial cystitis. J. Urol. 1993; 150: 2007–2012.
- 32 Stefansson K, Wollmann RL, Moore BW. Distribution of S-100 protein outside the central nervous system. Brain Res. 1982; 234: 309–17.
- 33 Sugimura K, Haimoto H, Nagura H, Kato K, Takahashi A. Immunohistochemical differential distribution of S-100 alpha and S-100 beta in the peripheral nervous system of the rat. Muscle Nerve. 1989; 12: 929–35.
- 34 Peeker R, Aldenborg F, Haglid K, Johansson SL, Rosengren L, Fall M. Decreased levels of S100 protein in non-ulcer interstitial cystitis. Scand. J. Urol. Nephrol. 1998; 32: 395–8.
- 35 Peeker R, Aldenborg F, Dahlstrom A, Johansson SL, Li JY, Fall M. Increased tyrosine hydroxylase immunoreactivity in bladder tissue from patients with classic and nonulcer interstitial cystitis. J. Urol. 2000; 163: 1112–15.
- 36 Elbadawi AE, Light JK. Distinctive ultrastructural pathology of nonulcerative interstitial cystitis: new observations and their potential significance in pathogenesis. Urol Int. 1996; 56: 137–62.
- 37 Parsons CL, Bautista SL, Stein PC, Zupkas P. Cyto-injury factors in urine: a possible mechanism for the development of interstitial cystitis. J. Urol. 2000; 164: 1381–4.
- 38 Rosamilia A, Cann L, Scurry J, Rogers P, Dwyer P. Bladder microvasculature and the effects of hydrodistention in interstitial cystitis. Urology. 2001; 57: 132.
- 39 Pontari MA, Hanno PM, Ruggieri MR. Comparison of bladder blood flow in patients with and without interstitial cystitis. J. Urol. 1999; 162: 330–4.
- 40 Theoharides TC, Pang X, Letourneau R, Sant GR. Interstitial cystitis: a neuroimmunoendocrine disorder. Ann. NY Acad. Sci. 1998; 840: 619–34.
- 41 iOkragly AJ, Niles AL, Saban R et al. Elevated tryptase, nerve growth factor, neurotrophin-3 and glial cell line-derived neurotrophic factor levels in the urine of interstitial cystitis and bladder cancer patients. J. Urol. 1999; 161: 438–41.
- 42 Abdel-Mageed AB, Ghoniem GM. Potential role of rel/nuclear factor-kappa B in the pathogenesis of interstitial cystitis. J. Urol. 1998; 160: 2000–2003.
- 43 Ueda T, Tamaki M, Ogawa O, Yoshimura N. Over expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in patients with interstitial cystitis and bladder carcinoma. J. Urol. 2002; 167: 347–51.
- 44 Oravisto KJ. Epidemiology of interstitial cystitis. Ann. Chir. Gynaecol. Fenn. 1975; 64: 75–7.
- 45 Leppilahti M, Tammela TLJ, Huhtala H, Auvinen A. Prevalence of symptoms related to interstitial cystitis in women: a population based study in Finland. J. Urol. 2002; 168: 139–43.
- 46 Leppilahti M, Sairanen J, Tammela TLJ, Aaltomaa S, Lehtoranta K, Auvinen A. Prevalence of clinically confirmed interstitial cystitis in women: a population based study in Finland. J. Urol. 2005; 174: 581–3.
- 47 Temml C, Wehrberger C, Riedl C, Ponholzer A, Marszalek M, Madersbacher S. Prevalence and correlates for interstitial cystitis symptoms in women participating in a health screening project. Eur. Urol. 2007; 51: 803–8.
- 48 Jones CA, Harris M, Nyberg L. Prevalence of interstitial cystitis in the United States. J. Urol. 1994; 151: 423A.
- 49 Curhan GC, Speizer FE, Hunter DJ, Curhan SG, Stampfer MJ. Epidemiology of interstitial cystitis: a population based study. J. Urol. 1999; 161: 549–52.
- 50 Clemens JQ, Meenan RT, Rosetti MCO, Gao SY, Calhoun EA. Prevalence and incidence of interstitial cystitis in a managed care population. J. Urol. 2005; 173: 98–102.
- 51 Ito T, Miki M, Yamada T. Interstitial cystitis in Japan. BJU Int. 2000; 86: 634–7.
- 52 Ito T, Ueda T, Takei M, Homma Y. Recent trends in patient characteristics and therapeutic choices for interstitial cystitis: analysis of 282 Japanese patients. Int. J. Urol. 2004; 14: 1068–70.
- 53 Homma Y, Kakizaki H, Goto M, Takei M, Yamanishi T, Hayashi K. Epidemiological study of urination. Nihonhainyoukinougakkaizasshi 2003; 14: 266–77.
- 54 Simon LJ, Landis JR, Erickson DR, Nyberg LM. The Interstitial Cystitis Data Base Study: concepts and preliminary baseline descriptive statistics. Urology 1997; 49 (Suppl 5A): 64–75.
- 55 Michael YL, Kawachi I, Stampfer MJ, Colditz GA, Curhan GC. Quality of life among women with interstitial cystitis. J. Urol. 2000; 164: 423–7.
- 56 Rothrock NE, Lutgendorf SK, Kreder KJ. Coping strategies in patients with interstitial cystitis: relationships with quality of life and depression. J. Urol. 2003; 169: 233–6.
- 57 Homma Y. The Symptoms of IC and QOL. Voiding Disorders Digest. 2004; 12: 15–22.
- 58 Goldman HB. Interstitial cystitis: the great enigma. J. Urol. 2000; 164: 1921.
- 59 Gillenwater JY, Wein AJ. Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28–29, 1987. J. Urol. 1988; 140: 203–6.
- 60 Kusek JW, Nyberg LM. The epidemiology of interstitial cystitis: is it time to expand our definition? Urology 2001; 57: 95–9.
- 61 Dell JR. Chronic pelvic pain of bladder origin: a focus on interstitial cystitis. Int. J. Fertil. Womens Med. 2003; 48: 154–62.
- 62 Ajibona OO, Kehinde EO. Interstitial cystitis: a review of current concepts of aetiology, diagnosis and therapy. Scand. J. Urol. Nephrol. 2003; 37: 253–8.
- 63 Simon LJ, Landis JR, Erickson DR, Nyberg LM. The Interstitial Cystitis Data Base Study: concepts and preliminary baseline descriptive statistics. Urology 1997; 49: 64–75.
- 64 Lutgendorf SK, Kreder KJ, Rothrock NE, Ratliff TL, Zimmerman B. Stress and symptomatology in patients with interstitial cystitis: a laboratory stress model. J. Urol. 2000; 164: 1265–9.
- 65 O'Leary MP, Sant GR, Fowler FJ Jr, Whitmore KE, Spolarich-Kroll J. The interstitial cystitis symptom index and problem index. Urology 1997; 49 (Suppl 5A): 58–63.
- 66 Ito T, Ueda T, Takei M, Honma Y. Interstitial cystitis in Japan: Clinical statistics of 282 cases and recent trend. J. Int. Cyst. 2004; 2: 19–23.
- 67 Messing EM, Stamey TA. Interstitial cystitis: early diagnosis, pathology, and treatment. Urology 1978; 12: 381–92.
- 68 Driscoll A, Teichman JMH. How do patients with interstitial cystitis present? J. Urol. 2001; 166: 2118–20.
- 69 Irwin P, Samsudin A. Reinvestigation of patients with a diagnosis of interstitial cystitis: common things are sometimes common. J. Urol. 2005; 174: 584–7, discussion 587.
- 70 Sant GR, Hanno PM. Interstitial cystitis: current issues and controversies in diagnosis. Urology 2001; 57: 82–8.
- 71 Frazer MI, Haylen BT, Sissons M. Do women with idiopathic sensory urgency have early interstitial cystitis? Br. J. Urol. 1990; 66: 274–8.
- 72 Awad SA, MacDiarmid S, Gajewski JB, Gupta R. Idiopathic reduced bladder storage versus interstitial cystitis. J. Urol. 1992; 148: 1409–12.
- 73 Al-Hadithi H, Tincello DG, Vince GS, Richmond DH. Leukocyte populations in interstitial cystitis and idiopathic reduced bladder storage. Urology 2002; 59: 851–5.
- 74 Waxman JA, Sulak PJ, Kuehl TJ. Cystoscopic findings consistent with interstitial cystitis in normal women undergoing tubal ligation. J. Urol. 1998; 160: 1663–7.
- 75 Messing E, Pauk D, Schaeffer A et al. Associations among cystoscopic findings and symptoms and physical examination findings in women enrolled in the Interstitial Cystitis Data Base (ICDB) Study. Urology 1997; 49: 81–5.
- 76 Mattila J. Vascular immunopathology in interstitial cystitis. Clin. Immunol. Immunopathol. 1982; 23: 648–55.
- 77 Gillespie L, Said J, Sostrin S, Kleiwer K. Immunofluorescent and histochemical staining confirm the identification of the many diseases called interstitial cystitis. Br. J. Urol. 1990; 66: 265–73.
- 78 Lynes WL, Flynn SD, Shortliffe LD, Stamey TA. The histology of interstitial cystitis. Am. J. Surg. Pathol. 1990; 14: 969–76.
- 79 Rosamilia A, Igawa Y, Higashi S. Pathology of interstitial cystitis. Int. J. Urol 2003; 10 (Suppl): S11–15.
- 80 Parsons CL, Greenberger M, Gabal L, Bidair M, Barme G. The role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis. J. Urol. 1998; 159: 1862–1867.
- 81 Chambers GK, Fenster H. Re: the role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis. J. Urol. 1999; 161: 1581–2.
- 82 Gregoire M, Liandier F, Naud A, Lacombe L, Fradet Y. Does the potassium stimulation test predict cystometric, cystoscopic outcome in interstitial cystitis? J. Urol. 2002; 168: 556–7.
- 83 Keay SK, Szekely Z, Conrads TP et al. An antiproliferative factor from interstitial cystitis patients is a frizzled 8 protein-related sialoglycopeptide. Proc. Natl Acad. Sci. USA 2004; 101: 11803–8.
- 84 Keay S, Zhang CO, Chai T et al. Antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor in men with interstitial cystitis versus chronic pelvic pain syndrome. Urology 2004; 63: 22–6.
- 85 Chaiken DC, Blaivas JG, Blaivas ST. Behavioral therapy for the treatment of refractory interstitial cystitis. J. Urol. 1993; 149: 1445–8.
- 86 Parsons CL, Koprowski PF. Interstitial cystitis: successful management by increasing urinary voiding intervals. Urology 1991; 37: 207–12.
- 87 Mendelowitz F, Moldwin R. Complementary approaches in the management of interstitial cystitis. In: GR Sant (ed.) Interstitial Cystitis. Philadelphia, PA: Lippincott-Raven, 1997; 235–9.
- 88 Lukban J, Whitmore K, Kellogg-Spadt S, Bologna R, Lesher A, Fletcher E. The effect of manual physical therapy in patients diagnosed with interstitial cystitis, high-tone pelvic floor dysfunction, and sacroiliac dysfunction. Urology 2001; 57 (Suppl 1): 121–2.
- 89 Holzberg A, Kellog-Spadt S, Lukban J, Whitmore K. Evaluation of transvaginal thiele massage as a therapeutic intervention for women with interstitial cystitis. Urology 2001; 57 (Suppl 1): 120.
- 90 Weiss JM. Pelvic floor myofascial trigger points: manual therapy for interstitial cystitis and the urgency-frequency syndrome. J. Urol. 2001; 166: 2226–31.
- 91 Markwell SJ. Physical therapy management of pelvic/perineal and perianal pain syndromes. World J. Urol. 2001; 19: 194–9.
- 92 Meadows E. Treatments for patients with pelvic pain. Urol. Nur. 1999; 19: 33–5.
- 93 Lukban JC, Whitmore KE. Pelvic floor muscle re-education treatment of the overactive bladder and painful bladder syndrome. Clin. Obstet. Gynecol. 2002; 45: 273–85.
- 94 Webster DC, Brennan T. Self-care effectiveness and health outcomes in women with interstitial cystitis: implications for mental health clinicians. Iss. Ment Health Nurs. 1998; 19: 495–519.
- 95 Koziol JA, Clark DC, Gittes RF, Tan EM. The natural history of interstitial cystitis: a survey of 374 patients. J. Urol. 1993; 149: 465–9.
- 96 Rothrock NE, Lutgendorf SK, Kreder KJ, Ratliff T, Zimmerman B. Stress and symptoms in patients with interstitial cystitis: a life stress model. Urology 2001; 57: 422–7.
- 97 McCormick NB. Psychological aspects of interstitial cystitis. In: GR Sant (ed.). Interstitial Cystitis. Philadelphia, PA: Lippincott-Raven, 1997; 193–2003.
- 98 Whitmore KE. Self-care regimens for patients with interstitial cystitis. Urol Clin. North Am. 1994; 21: 121–30.
- 99 Chung MK. Interstitial cystitis in persistent posthysterectomy chronic pelvic pain. JSLS 2004; 8: 329–33.
- 100 Nickel JC. Interstitial cystitis. Etiology, diagnosis, and treatment. Can. Fam. Physician 2000; 46: 2430–4, 2437–2440.
- 101 Gillespie L. Metabolic appraisal of the effects of dietary modification on hypersensitive bladder symptoms. Br. J. Urol. 1993; 72: 293–7.
- 102 Moldwin RM, Sant GR. Interstitial cystitis: a pathophysiology and treatment update. Clin. Obstet. Gynecol. 2002; 45: 259–72.
- 103 Webster DC, Brennan T. Self-care strategies used for acute attack of interstitial cystitis. Urol. Nurs. 1995; 15: 86–93.
- 104 Webster DC, Brennan T. Use and effectiveness of physical self-care strategies for interstitial cystitis. Nurse Pract. 1994; 19: 55–61.
- 105 Bade JJ, Peeters JM, Mensink HJ. Is the diet of patients with interstitial cystitis related to their disease? Eur. Urol. 1997; 32: 179–83.
- 106 Koziol JA. Epidemiology of interstitial cystitis. Urol Clin. North Am. 1994; 21: 7–20.
- 107 Erickson DR, Davies MF. Interstitial cystitis. Int. Urogynecol. J. Pelvic Floor Dysfunct. 1998; 9: 174–83.
- 108 Bade JJ, Rijcken B, Mensink HJ. Interstitial cystitis in the Netherlands: prevalence, diagnostic criteria and therapeutic preferences. J. Urol. 1995; 154: 2035–7, discussion 2037–2038.
- 109 Rovner E, Propert KJ, Brensinger C and the Interstitial Cystitis Data Base Study Group. Treatments used in women with interstitial cystitis: The Interstitial Cystitis Data Base (ICDB) study experience. Urology 2000; 56: 940–5.
- 110 Bumpus HC Jr. Interstitial cystitis: its treatment by overdistention of the bladder. Med. Clin. North Am. 1930; 13: 1495–8.
- 111 Yamada T, Murayama T, Andoh M. Adjuvant hydrodistension under epidural anesthesia for interstitial cystitis. Int. J. Urol. 2003; 10: 463–9.
- 112 Dunn M, Ramsden PD, Roberts JB, Smith JC, Smith PJ. Interstitial cystitis, treated by prolonged bladder distension. Br. J. Urol. 1977; 49: 641–5.
- 113 Glemain P, Riviere C, Lenormand L, Karam G, Bouchot O, Buzelin JM. Prolonged hydro-distention of the bladder for symptomatic treatment of interstitial cystitis: efficacy at 6 months and 1 year. Eur. Urol. 2002; 41: 79–84.
- 114 Hanno PM, Wein AJ. Conservative therapy of interstitial cystitis. Semin Urol. 1991; 9: 143–7.
- 115 Tomoe H, Kobayashi H, Nakazawa H, Toma H. The efficacy of hydrodistension of the bladder for interstitial cystitis. J. Interstit. Cyst. 2004; 2: 24–31.
- 116 Gosling JA, Dixon JS, Dunn M. The structure of the rabbit urinary bladder after experimental distension. Invest. Urol. 1977; 14: 386–9.
- 117 Lasanen LT, Tammela TL, Kallioinen M, Waris T. Effect of acute distension on cholinergic innervation of the rat urinary bladder. Urol. Res. 1992; 20: 59–62.
- 118 Taub HC, Stein M. Bladder distension therapy for symptomatic relief of frequency and urgency: a ten-year review. Urology 1994; 43: 36–9.
- 119 Higson RH, Smith JC, Whelan P. Bladder rupture: an acceptable complication of distension therapy? Br. J. Urol. 1978; 50: 529–34.
- 120 Uchida E, Ishimaru R, Mukubo Y, Tomoe H, Nakazawa H, Kawamata M. Patient satisfaction with anesthesia for hydrodistension during perioperative period. Nippon Hinyokika Gakkai Zasshi 2005; 96: 274.
- 121 Minogiannis P, El-Mansoury M, Betances JA, Sant GR, Theoharides TC. Hydroxyzine inhibits neurogenic bladder mast cell activation. Int. J. Immunopharmacol. 1998; 20: 553–63.
- 122 Simmons JL, Bunce PL. On the use of antihistamine in the treatment of interstitial cystitis. Am. Surg. 1958; 24: 664–7.
- 123 Simmons JL. Interstitial cystitis: an explanation for the beneficial effect of an antihistamine. J. Urol. 1961; 85: 149–55.
- 124 Theoharides TC. Hydroxyzine for interstitial cystitis. J. Allergy Clin. Immunol. 1993; 91: 686–7.
- 125 Theoharides TC. Hydroxyzine in the treatment of interstitial cystitis. Urol. Clin. North Am. 1994; 21: 113–19.
- 126 Sant GR, Propert KJ, Hanno PM et al. A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. J. Urol. 2003; 170: 810–15.
- 127 Hanno PM, Wein AJ. Medical treatment of interstitial cystitisiother than Rimso-50/Elmironi. Urology 1987; 29: 22–6.
- 128 Hanno PM, Wein AJ. Conservative therapy of interstitial cystitis. Semin Urol. 1991; 9: 143–7.
- 129 Pranikoff K, Constantino G. The use of amitriptyline in patients with urinary frequency and pain. Urology 1998; 51: 179–81.
- 130 Kirkemo AK, Miles BJ, Peters JM. Use of amitriptyline in interstitial cystitis. J. Urol. 1990; 143: 279A.
- 131 van Ophoven A, Pokupik S, Heinecke A, Hertle L. A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis. J. Urol. 2004; 172: 533–6.
- 132 van Ophoven A, Hertle L. Long-term results of amitriptyline treatment for interstitial cystitis. J. Urol. 2005; 174: 1837–40.
- 133 Ueda T, Tamaki M, Ogawa O, Yamauchi T, Yoshimura N. Improvement of interstitial cystitis symptoms and problems that developed during treatment with oral IPD-1151T. J. Urol. 2000; 164: 1917–20.
- 134 Seshadri P, Emerson L, Morales A. Cimetidine in the treatment of interstitial cystitis. Urology 1994; 44: 614–16.
- 135 Lewi H. Cimetidine in the treatment of interstitial cystitis. Urology. 1995; 45: 1088.
- 136 Lewi H. Medical therapy in interstitial cystitis: the Essex experience. Urology 2001; 57 (Suppl 1): 120.
- 137 Thilagarajah R, Witherow RO'N, Walker MM. Oral cimetidine gives effective symptom relief in painful bladder disease: a prospective, randomized, double-blind placebo-controlled trial. BJU Int. 2001; 87: 207–12.
- 138 Warren JW, Horne LM, Hebel JR, Marvel RP, Keay SK, Chai TC. Pilot study of sequential oral antibiotics for the treatment of interstitial cystitis. J. Urol. 2000; 163: 1685–8.
- 139 Badenoch AW. Chronic interstitial cystitis. Br. J. Urol. 1971; 43: 718–21.
- 140 Soucy F, Gregorie M. Efficacy of prednisone for severe refractory ulcerative interstitial cystitis. J. Urol. 2005; 173: 841–3.
- 141 Smith SD, Wheeler MA, Foster HE Jr, Weiss RM. Improvement in interstitial cystitis symptom scores during treatment with oral L-arginine. J. Urol. 1997; 158: 703–8.
- 142 Ehren I, Lundberg JON, Adolfsson J, Wiklund NP. Effects of L-arginine treatment on symptoms and bladder nitric oxide levels in patients with interstitial cystitis. Urology. 1998; 52: 1026–9.
- 143 Korting GE, Smith SD, Wheeler MA, Weiss RM, Foster HE Jr. A randomized double-blind trial of oral L-arginine for treatment of interstitial cystitis. J. Urol. 1999; 161: 558–65.
- 144 Cartledge JJ, Davies AM, Eardley I. A randomized double-blind placebo-controlled crossover trial of the efficacy of L-arginine in the treatment of interstitial cystitis. BJU Int. 2000; 85: 421–6.
- 145 Barrington JW, Stephenson TP. Pentosanpolysulphate for interstitial cystitis. Int. Urogynecol. J. Pelvic Floor Dysfunct. 1997; 8: 293–5.
- 146 Parsons CL, Schmidt JD, Pollen JJ. Successful treatment of interstitial cystitis with sodium pentosanpolysulfate. J. Urol. 1983; 130: 51–3.
- 147 Fritjofsson A, Fall M, Juhlin R, Persson BE, Ruutu M. Treatment of ulcer and nonulcer interstitial cystitis with sodium pentosanpolysulfate: a multicenter trial. J. Urol. 1987; 138: 508–12.
- 148 Holm-Bentzen M, Jacobsen F, Nerstrom B et al. A prospective double-blind clinically controlled multicenter trial of sodium pentosanpolysulfate in the treatment of interstitial cystitis and related painful bladder disease. J. Urol. 1987; 138: 503–7.
- 149 Mulholland SG, Hanno P, Parsons CL, Sant GR, Staskin DR. Pentosan polysulfate sodium for therapy of interstitial cystitis. A double-blind placebo-controlled clinical study. Urology 1990; 35: 552–8.
- 150 Parsons CL, Benson G, Childs SJ, Hanno P, Sant GR, Webster G. A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate. J. Urol. 1993; 150: 845–8.
- 151 Hanno PM. Analysis of long-term Elmiron therapy for interstitial cystitis. Urology 1997; 49 (Suppl 1): 93–9.
- 152 Forsell T, Ruutu M, Isoniemi H, Ahonen J, Alfthan O. Cyclosporine in severe interstitial cystitis. J. Urol. 1996; 155: 1591–3.
- 153 Sairanen J, Forsell T, Ruutu M. Long-term outcome of patients with interstitial cystitis treated with low dose cyclosporine A. J. Urol. 2004; 171: 2138–41.
- 154 Sairanen J, Tammela TL, Leppilathi M et al. Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis; a ramdomized comparative study. J. Urol. 2005; 174: 2235–8.
- 155 Peeker R, Haghsheno MA, Holmang S, Fall M. Intravesical bacillus Calmette-Guerin and dimethyl sulfoxide for treatment of classic and nonulcer interstitial cystitis: a prospective, randomized double-blind study. J. Urol. 2000; 164: 1912–16.
- 156 Perez-Marrero R, Emerson LE, Feltis JT. A controlled study of dimethyl sulfoxide in interstitial cystitis. J. Urol. 1988; 140: 36–9.
- 157 Ruiz JL, Alonso M, Moreno B, Server G, Osca JM, Jimenez JF. Dimethyl sulfoxide in the treatment of interstitial cystitis. Actas Urol. Esp. 1991; 15: 357–60.
- 158 Fowler JE. Prospective study of intravesical dimethyl sulfoxide in the treatment of suspected early interstitial cystitis. Urology 1981; 18: 21–6.
- 159 Rossberger J, Fall M, Peeker R. Critical appraisal of dimethyl sulfoxide treatment for interstitial cystitis discomfort, side effect and treatment outcome. Scand. J. Urol. Nephrol. 2005; 39: 73–7.
- 160 Sant GR. Intravesical 50% dimethyl sulfoxideiRimso-50iin treatment of interstitial cystitis. Urology 1987; 29 (Suppl): 17–21.
- 161 Kuo HC. Urodynamic results of intravesical heparin therapy for women with frequency urgency syndrome and interstitial cystitis. J. Formos Med. Assoc. 2001; 100: 309–14.
- 162 Parsons CL, Housley T, Schmidt JD, Lebow D. Treatment of interstitial cystitis with intravesical heparin. Br. J. Urol. 1994; 73: 504–7.
- 163 Parsons CL. Successful downregulation of bladder sensory nerves with combination of heparin and alkalinized lidocaine in patients with interstitial cystitis. Urology 2005; 65: 45–8.
- 164 Leppilahti M, Hellstrom P, Tammela TLJ. Effect of diagnostic hydrodistension and four intravesical hyaluronic acid instillations on bladder ICAM-1 intensity and association of ICAM1 intensity with clinical response in patients with interstitial cystitis. Urology 2002; 60: 46–51.
- 165 Porru D, Campus G, Tudino D et al. Results of treatment of refractory interstitial cystitis with intravesical hyaluronic acid. Urol. Int. 1997; 59: 26–9.
- 166 Morales A, Emerson L, Nickel JC. Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. Urology 1997; 49 (Suppl 1): 111–13.
- 167 Morales A, Emerson L, Nickel JC, Lundie M. Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. J. Urol. 1996; 156: 45–8.
- 168 Kallestrup EB, Jorgensen SS, Nordling J, Hald T. Treatment of interstitial cystitis with Cystat: a hyaluronic acid product. Scand. J. Urol. Nephrol. 2005; 39: 143–7.
- 169 Steinhoff G, Ittah B, Rowan S. The efficacy of chondroitin sulfate 0.2% in treating interstitial cystitis. Can. J. Urol. 2002; 9: 1454–8.
- 170 Bade JJ, Laseur M, Nieuwenburg A, van der Weele LT, Mensink HJ. A placebo-controlled study of intravesical pentosanpolysulphate for the treatment of interstitial cystitis. Br. J. Urol. 1997; 79: 168–71.
- 171 Fagerli J, Fraser MO, deGroat WC et al. Intravesical capsaicin for the treatment of interstitial cystitis: a pilot study. Can. J. Urol. 1999; 6: 737–44.
- 172 Lazzeri M, Spinelli M, Beneforti P, Malaguti S, Giardiello G, Turini D. Intravesical infusion of resiniferatoxin by a temporary in situ drug delivery system to treat interstitial cystitis: a pilot study. Eur. Urol. 2004; 45: 98–102.
- 173 Chen TY, Corcos J, Camel M, Ponsot Y, Tu le M. Prospective, randomized double-blind, study of safety and tolerability of intravesical resiniferatoxin (RTX in interstitial cystitis (IC). Int. Urogynecol. J. Pelvic Floor Dysfunct. 2005; 16: 293–7.
- 174 Payne CK, Mosbaugh PG, Forrest JB et al. Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double blind, placebo controlled trial. J. Urol. 2005; 173: 1590–4.
- 175 Peters K, Diokno A, Steinert B et al. The efficacy of intravesical Tice strain bacillus Calmette-Guerin in the treatment of interstitial cystitis: a double-blind, prospective, placebo controlled trial. J. Urol. 1997; 157: 2090–2094.
- 176 Peters KM, Diokno AC, Steinert BW, Gonzalez JA. The efficacy of intravesical bacillus Calmette-Guerin in the treatment of interstitial cystitis: long-term follow up. J. Urol. 1998; 159: 1483–7.
- 177 Zeidman EJ, Helfrick B, Pollard C, Thompson IM. Bacillus Calmette-Guerin immunotherapy for refractory interstitial cystitis. Urology 1994; 43: 121–4.
- 178 Mayer R, Propert KJ, Peters KM et al. A randomized controlled trial of intravesical bacillus calmette-guerin for treatment of refractory interstial cystitis. J. Urol. 2005; 173: 1186–91.
- 179 Barbalias GA, Liatsikos EN, Athanasopoulos A, Nikiforidis G. Interstitial cystitis: bladder training with intravesical oxybutynin. J. Urol. 2000; 163: 1818–22.
- 180 Riedl CR, Knoll M, Plas E, Pfluger H. Electromotive drug administration and hydrodistention for the treatment of interstitial cystitis. J. Endourol. 1998; 12: 269–72.
- 181 Rosamilia A, Dwyer PL, Gibson J. Electromotive drug administration of lidocaine and dexamethasone followed by cystodistension in women with interstitial cystitis. Int. Urogynecol. J. Pelvic Floor Dysfunct. 1997; 8: 142–5.
- 182 Riedl CR, Knoll M, Plas E, Stephen RL, Pfluger H. Intravesical electromotive drug administration for the treatment of non-infectious chronic cystitis. Int. Urogynecol. J. Pelvic Floor Dysfunct. 1997; 8: 134–7.
- 183 Gurpinar T, Wong HY, Griffith DP. Electromotive administration of intravesical lidocaine in patients with interstitial cystitis. J. Endourol. 1996; 10: 443–7.
- 184 Chuang YC, Yoshimura N, Haung CC, Chiang PH, Chancellor M. Intravesical botulinum toxin a administration produces analgesia against acetic acid induced bladder pain responses in rats. J. Urol. 2004; 172: 1529–32.
- 185 Smith CP, Radziszewski P, Borkowski A, Somogyi GT, Boone TB, Chancellor MB. Botulinum toxin A has antinociceptive effects in treating interstitial cystitis. Urology 2004; 64: 871–5.
- 186 Fall M. Conservative management of chronic interstitial cystitis: transcutaneous electrical nerve stimulation and transurethral resection. J. Urol. 1985; 133: 774–8.
- 187 Fall M, Lindstrom S. Transcutaneous electrical nerve stimulation in classic and nonulcer interstitial cystitis. Urol. Clin. North Am. 1994; 21: 131–9.
- 188
Geirsson G,
Wang YH,
Lindstrom S,
Fall M.
Traditional acupuncture and electrical stimulation of the posterior tibial nerve. A trial in chronic interstitial cystitis.
Scand. J. Urol Nephrol. 1993; 27: 6770.
10.3109/00365599309180416 Google Scholar
- 189 Bristow SE, Hasan ST, Neal DE. TENS: a treatment option for bladder dysfunction. Int. Urogynecol J. Pelvic Floor Dysfunct. 1996; 7: 185–90.
- 190 Whitmore KE, Payne CK, Diokno AC, Lukban JC. Sacral neuromodulation in patients with interstitial cystitis: a multicenter clinical trial. Int. Urogynecol. J. Pelvic Floor Dysfunct. 2003; 14: 305–9.
- 191 Peters KM. Neuromodulation for the treatment of refractory interstitial cystitis. Rev. Urol. 2002; 4 (Suppl 1): S36–43.
- 192 Maher CF, Carey MP, Dwyer PL, Schluter PL. Percutaneous sacral nerve root neuromodulation for intractable interstitial cystitis. J. Urol. 2001; 165: 884–6.
- 193 Comiter CV. Sacral neuromodulation for the symptomatic treatment of refractory interstitial cystitis: a prospective study. J. Urol. 2003; 169: 1369–73.
- 194 Zermann DH, Weirich T, Wunderlich H, Reichelt O, Schubert J. Sacral nerve stimulation for pain relief in interstitial cystitis. Urol Int. 2000; 65: 120–1.
- 195 Chang PL. Urodynamic studies in acupuncture for women with frequency, urgency and dysuria. J. Urol. 1988; 140: 563–6.
- 196 Chang PL, Wu CJ, Huang MH. Long-term outcome of acupuncture in women with frequency, urgency and dysuria. Am. J. Chin. Med. 1993; 21: 231–6.
- 197 O'Reilly BA, Dwyer PL, Hawthorne G et al. Transdermal posterior tibial nerve laser therapy is not effective in women with interstitial cystitis. J. Urol. 2004; 172: 1880–3.
- 198 Kerr WS Jr. Interstitial cystitis: treatment by transurethral resection. J. Urol. 1971; 105: 664–6.
- 199 Peeker R, Aldenborg F, Fall M. Complete transurethral resection of ulcers in classic interstitial cystitis. Int. Urogynecol. J. Pelvic Floor Dysfunct. 2000; 11: 290–5.
- 200 Greenberg E, Barnes R, Stewart S, Furnish T. Transurethral resection of Hunner's ulcer. J. Urol. 1974; 111: 764–6.
- 201 Shanberg AM, Baghdassarian R, Tansey LA. Treatment of interstitial cystitis with the neodymium-YAG laser. J. Urol. 1985; 134: 885–8.
- 202 Shanberg AM, Malloy T. Treatment of interstitial cystitis with neodymium: YAG laser. Urology 1987; 29 (Suppl): 31–3.
- 203 Malloy TR, Shanberg AM. Laser therapy for interstitial cystitis. Urol Clin. North Am. 1994; 21: 141–4.
- 204 Rofeim O, Hom D, Freid RM, Moldwin RM. Use of the neodymium : YAG laser for interstitial cystitis: a prospective study. J. Urol. 2001; 166: 134–6.
- 205 van Ophoven A, Oberpenning F, Hertle L. Long-term results of trigone-preserving orthotopic substitution enterocystoplasty for interstitial cystitis. J. Urol. 2002; 167: 603–7.
- 206 Irwin PP, Galloway NT. Surgical management of interstitial cystitis. Urol Clin. North Am. 1994; 21: 145–51.
- 207 Linn JF, Hohenfellner M, Roth S et al. Treatment of interstitial cystitis: comparison of subtrigonal and supratrigonal cystectomy combined with orthotopic bladder substitution. J. Urol. 1998; 159: 774–8.
- 208 Kontturi MJ, Hellstrom PA, Tammela TL, Lukkarinen OA. Colocystoplasty for the treatment of severe interstitial cystitis. Urol. Int. 1991; 46: 50–4.
- 209 Nielsen KK, Kromann-Andersen B, Steven K, Hald T. Failure of combined supratrigonal cystectomy and Mainz ileocecocystoplasty in intractable interstitial cystitis: is histology and mast cell count a reliable predictor for the outcome of surgery? J. Urol. 1990; 144: 255–9.
- 210 Peeker R, Aldenborg F, Fall M. The treatment of interstitial cystitis with supratrigonal cystectomy and ileocystoplasty: difference in outcome between classic and nonulcer disease. J. Urol. 1998; 159: 1479–82.
- 211 Nurse DE, Parry JR, Mundy AR. Problems in the surgical treatment of interstitial cystitis. Br. J. Urol. 1991; 68: 153–4.
- 212 Chakravarti A, Ganta S, Somani B, Jones MA. Caecocystoplasty for intractable interstitial cystitis: long-term results. Eur. Urol. 2004; 46: 114–17.
- 213 Gershbaum D, Moldwin R. Practice trends for the management of interstitial cystitis. Urology. 2001; 57: 119.
- 214 Baskin LS, Tanagho EA. Pelvic pain without pelvic organs. J. Urol. 1992; 147: 683–6.
- 215 Blaivas JG, Weiss JP, Desai P, Flisser AJ, Stember DS, Stahl PJ. Long-term follow up of augmentation enterocystoplasty and continent diversion in patients with benign disease. J. Urol. 2005; 173: 1631–4.
- 216 Elzawahri A, Bissada NK, Herchorn S et al. Urinary conduit formation using a retubularized bowel from continent urinary diversion or intestinal augmentations: ii. Does it have a role in patients with interstitial cystitis? J. Urol. 2004; 171: 1559–62.
- 217 Freiha FS, Faysal MH, Stamey TA. The surgical treatment of intractable interstitial cystitis. J. Urol. 1980; 123: 632–4.
- 218 Messing EM, Stamey TA. Interstitial cystitis: early diagnosis, pathology, and treatment. Urology 1978; 12: 381–92.
- 219 Hanno PM, Landis JR, Matthews-Cook Y, Kusek J, Nyberg L Jr. The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health Interstitial Cystitis Database study. J. Urol. 1999; 161: 553–7.
- 220 Fall M, Aldenborg F, Johansson S, Peeker R. Clinical characteristics support that interstitial cystitis is a heterogeneous syndrome. Urology 2001; 57: 129–30.
Citing Literature
